UK Centre for Tobacco and Alcohol Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK.
Shaping Public hEalth poliCies To Reduce IneqUalities and harM (SPECTRUM), London, UK.
Addiction. 2020 Apr;115(4):782-783. doi: 10.1111/add.14920. Epub 2020 Jan 16.
To determine whether nicotine-containing vaping products submitted to the Medicines and Healthcare products Regulatory Agency (MHRA) under the Tobacco and Related Products Regulations 2016 contain tetrahydrocannabinol or vitamin E acetate.
Analysis of data on ingredients for all products submitted for notification for the UK market by October 2017 to assess whether any were reported to contain vitamin E acetate or tetrahydrocannabinol (THC). The analysis was not pre-registered and the results should therefore be considered exploratory.
Vitamin E acetate and THC were not listed as an ingredient or emission in any of the 41 809 products that were submitted for notification.
In the United Kingdom, vapers and those considering switching from tobacco to vaping can be reassured that licit products available on the UK market do not contain tetrahydrocannabinol or vitamin E acetate.
确定根据《2016 年烟草及相关制品法规》向药品和保健产品监管局(MHRA)提交的含尼古丁的蒸气类产品是否含有四氢大麻酚或维生素 E 醋酸盐。
对 2017 年 10 月前提交英国市场的所有产品的成分数据进行分析,以评估是否有产品报告含有维生素 E 醋酸盐或四氢大麻酚(THC)。该分析未预先注册,因此结果应被视为探索性的。
在提交通知的 41809 种产品中,没有一种产品将维生素 E 醋酸盐或四氢大麻酚列为成分或排放物。
在英国,蒸气类产品的使用者和那些考虑从烟草转向蒸气类产品的人可以放心,英国市场上提供的合法产品不含有四氢大麻酚或维生素 E 醋酸盐。